NCT07053722View on ClinicalTrials.gov

Observational Clinical Study of Patients With Muscle - Invasive Bladder Cancer Undergoing Bladder Preservation Therapy After Neoadjuvant Therapy

Not yet recruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Bladder (Urothelial, Transitional Cell) Cancer
Interventions
RADIATION

NA-TMT

After neoadjuvant therapy, patients choose trimodality therapy (TMT) for bladder preservation over radical cystectomy.

All Listed Sponsors
lead

Peking University First Hospital

OTHER